James Cavet
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Immunology top 5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Papers in
- Hematology 18
- Multiple Myeloma Research and Treatments 11
- Hematopoietic Stem Cell Transplantation 8
-
- T-cell and B-cell Immunology 3
- Immune Response and Inflammation 3
- Immune Cell Function and Interaction 3
- Co-authors
- Peter G. Middleton (6 shared papers)Anne M. Dickinson (6 shared papers)Susan Blair (2 shared papers)Barbara A. Wilson (2 shared papers)Tracy Howe (2 shared papers)Alex Molassiotis (2 shared papers)Graham Jackson (3 shared papers)Harriet Noreen (2 shared papers)
- Journals
- Blood (10 papers)British Journal of Haematology (2 papers)Patient (1 paper)Bone Marrow Transplantation (1 paper)Supportive Care in Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
James Cavet
17 papers receiving 1.5k citations
James Cavet's Hit Papers
Peers
Comparison fields: 5 of 79
- Hematology 953
- Immunology 402
- Oncology 465
- Genetics 117
- Transplantation 27
Countries citing papers authored by James Cavet
This map shows the geographic impact of James Cavet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Cavet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Cavet more than expected).
Fields of papers citing papers by James Cavet
This network shows the impact of papers produced by James Cavet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Cavet. The network helps show where James Cavet may publish in the future.
Co-authors
The 25 scholars most cited alongside James Cavet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study Hit paper breakdown → | 2011 | 692 |
| 2 | 2010 | 208 | |
| 3 | 1999 | 201 | |
| 4 | 2001 | 196 | |
| 5 | 2006 | 100 | |
| 6 | 2009 | 90 | |
| 7 | 2003 | 48 | |
| 8 | 2015 | 21 | |
| 9 | 1999 | 19 | |
| 10 | 2015 | 15 | |
| 11 | 2022 | 6 | |
| 12 | 2010 | 5 | |
| 13 | 2019 | 5 | |
| 14 | Predicting outcome in hematological stem cell transplantation. | 2002 | 3 |
| 15 | 2023 | 2 | |
| 16 | 2010 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2021 | 0 | |
| 19 | 2024 | 0 |
About James Cavet
James Cavet is a scholar working on Hematology, Immunology, Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Hematopoietic Stem Cell Transplantation (8 papers), Protein Degradation and Inhibitors (3 papers), T-cell and B-cell Immunology (3 papers), Immune Response and Inflammation (3 papers), Immune Cell Function and Interaction (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Hematology (953 citations), Immunology (402 citations), Oncology (465 citations), Genetics (117 citations) and Transplantation (27 citations). James Cavet has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Peter G. Middleton, Anne M. Dickinson, Susan Blair, Barbara A. Wilson, Tracy Howe, Alex Molassiotis, Graham Jackson, Harriet Noreen, Tadeusz Robak and Miriam Segall. Their work appears in journals such as Blood, British Journal of Haematology, Patient, Bone Marrow Transplantation and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.